- Citations, last 5 years
- 1 863
- Works, last 5 years
- 138
- h-index
- 102
- Scientists listed
- 15
- Grants since 2016
- 4
Grants received
2024–2026 · grant · Standard Grant
SBIR Phase I: Cell-Mediated Delivery of Targeted Protein Degraders
Aaron Welch · Sage Therapeutics (United States) · funded by National Science Foundation
2022–2024 · contract · N01
Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections and Emerging Infectious Diseases
Andrew Tomaras · Sage Therapeutics (United States) · funded by National Institutes of Health
2022–2023 · contract · N01
DEVELOPMENT OF A TREATMENT FOR MULTIDRUG RESISTANT GRAM NEGATIVE URINARY TRACT INFECTIONS
Andrew Tomaras · Sage Therapeutics (United States) · funded by National Institutes of Health
2016–2017 · research · R43
Novel small molecule inhibitors of LpxC for multi-drug resistant Gram-negative bacteria.
David Puerta · Sage Therapeutics (United States) · funded by National Institutes of Health